# Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects

> **NCT01603485** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 16 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Lersivirine Immediate-Release (fasted)
- **DRUG:** Lersivirine Modified-Release #1 (fasted)
- **DRUG:** Lersivirine Modified-Release #2 (fasted)
- **DRUG:** Lersivirine Modified-Release #3 (fasted)
- **DRUG:** Lersivirine Modified-Release (fed)

## Key facts

- **NCT ID:** NCT01603485
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01603485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01603485, "Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01603485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*